Lassman, A., Alexander, B., Berry, D., Buxton, M., Cavenee, W., Colman, H., … Wen, P. Y. (2024). OS09.7.A GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB. In Neuro-Oncology (Vol. 26, pp. v26–v27). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noae144.079

Lassman, A., B. Alexander, D. Berry, M. Buxton, W. Cavenee, H. Colman, J. De Groot, et al. “OS09.7.A GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB.” In Neuro-Oncology, 26:v26–27. Oxford University Press (OUP), 2024. https://doi.org/10.1093/neuonc/noae144.079.

Lassman A, Alexander B, Berry D, Buxton M, Cavenee W, Colman H, et al. OS09.7.A GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB. In: Neuro-Oncology. Oxford University Press (OUP); 2024. p. v26–7.

Lassman, A., et al. “OS09.7.A GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB.” Neuro-Oncology, vol. 26, no. Supplement_5, Oxford University Press (OUP), 2024, pp. v26–27. Crossref, doi:10.1093/neuonc/noae144.079.

Lassman A, Alexander B, Berry D, Buxton M, Cavenee W, Colman H, De Groot J, Ellingson B, Gordon G, Hyddmark EMV, Khasraw M, Lim M, Mellinghoff I, Mikkelsen T, Perry J, Powell A, Sulman E, Tanner K, Weller M, Yung WKA, Blondin N, Brenner A, Butt O, de la Fuente MI, Drappatz J, Iwamoto F, Kim L, Lee E, Mantica M, Nabors B, Newton H, Schiff D, Walbert T, Weathers S, Cloughesy T, Wen PY. OS09.7.A GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB. Neuro-Oncology. Oxford University Press (OUP); 2024. p. v26–v27.